Positions

Overview

  • In October 2015, Dr. Herbert Chen was named as the new Chairman of the Department of Surgery. A native of Wisconsin, Chen received his undergraduate degree from Stanford University and began his medical education at the Duke University School of Medicine, graduating in 1992. He completed his surgical residency in general surgery at Johns Hopkins in 1999, along with a postdoctoral research fellowship in 1997 and a surgical oncology and endocrinology fellowship in 2000. Dr. Chen came to UAB from the University of Wisconsin, where he was the Layton F. Rikkers, M.D., Chair in Surgical Leadership, chair of the Division of General Surgery, vice chair of Research for the Department of Surgery and professor in the departments of Surgery, Biomedical Engineering and Pediatrics. Dr. Chen is a specialist in endocrine surgery, a funded surgeon scientist, and a dedicated educator. Dr. Chen is an Associate/Section Editor for Annals of Surgery, Annals of Surgical Oncology, Scientific American Surgery, The Oncologist, and Journal of Surgical Research, and serves on six other editorial boards. He is also the Past-President of Association for Academic Surgery, the current Secretary-Treasurer for Surgical Biology Club II, and the current President-Elect for the Society of Clinical Surgery. Dr. Chen has mentored over 100 faculty, post-doctoral fellows, residents, medical students, and undergraduates in his lab.

    Dr. Chen’s clinical interests include endocrine and neuroendocrine disease with a focus on minimally invasive endocrine surgery. He has one of the largest experiences with radioguided parathyroidectomy (MIRP), and performs high volume thyroid and adrenal surgery. Dr. Chen’s laboratory focuses on the role of cellular signaling pathways in the differentiation and growth of neuroendocrine (NE) tumors including carcinoid, pancreatic islet cell, pheochromocytoma, and medullary thyroid cancer.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Analysis of Open Payments Receipts Among Surgical Faculty at a Large Academic InstitutionJournal of Surgical Research.  244:599-603. 2019
    2019 Are Tc-99m-Sestamibi Scans in Patients With Secondary Hyperparathyroidism and Renal Failure Needed?Journal of Surgical Research.  243:380-383. 2019
    2019 Factors Affecting Readmission After Pediatric Thyroid Resection: A National Surgical Quality Improvement Program-Pediatric EvaluationJournal of Surgical Research.  243:33-40. 2019
    2019 Retraction Notice to “Factors Affecting Readmission Following Pediatric Thyroid Resection: A NSQIP-P Evaluation” [Journal of Surgical Research 243 (2019) 33-4](S0022480419302938)(10.1016/j.jss.2019.05.002)Journal of Surgical Research.  243:R1. 2019
    2019 Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical ReferralOncologist.  24:e828-e834. 2019
    2019 Precisely Control Mitochondria with Light to Manipulate Cell Fate DecisionBiophysical Journal.  117:631-645. 2019
    2019 Prevalence of Thymic Parathyroids in Primary Hyperparathyroidism During Radioguided ParathyroidectomyClinical Medicine Insights : Endocrinology and Diabetes.  12. 2019
    2019 Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitorsCancers.  11. 2019
    2019 Growing Human Parathyroids in a Microphysiological System: A Novel Approach to Understanding and Developing New Treatments for HyperparathyroidismCells Tissues Organs.  206:54-61. 2019
    2019 Considerations for Thyroidectomy as Treatment for Graves DiseaseClinical Medicine Insights : Endocrinology and Diabetes.  12. 2019
    2019 Is Frozen-Section Analysis During Thyroid Operation Useful in the Era of Molecular Testing?Journal of The American College of Surgeons.  228:474-479. 2019
    2019 National Cancer Institute Centers and Society of Surgical Oncology Cancer Research SynergyJournal of Surgical Research.  236:92-100. 2019
    2019 A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor–guided antibody-drug conjugate: Perspectives on clinical response?Surgery2019
    2019 Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancersSurgery.  165:64-68. 2019
    2019 Four decades of the American Association of Endocrine Surgeons (AAES): Past, present, and futureSurgery2019
    2019 Gender and Racial Disparities in Survival After Surgery Among Papillary and Patients With Follicular Thyroid Cancer: A 45-Year ExperienceClinical Medicine Insights : Endocrinology and Diabetes.  12. 2019
    2019 Increasing Use of Thyroidectomy as Definitive Treatment for HyperthyroidismJournal of Surgical Research2019
    2019 Management of Gastrointestinal Neuroendocrine TumorsClinical Medicine Insights : Endocrinology and Diabetes.  12. 2019
    2019 Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatmentSurgery2019
    2019 Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and ValidationBiotechnology Journal2019
    2019 Who are you?Surgery2019
    2018 Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?Clinical Medicine Insights : Endocrinology and Diabetes.  11. 2018
    2018 Can imaging studies be omitted in patients with sporadic primary hyperparathyroidism?Journal of Surgical Research.  231:257-262. 2018
    2018 To admit or not to admit? Experience with outpatient thyroidectomy for Graves’ disease in a high-volume tertiary care centerAmerican Journal of Surgery.  216:985-989. 2018
    2018 Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White PaperAnnals of Surgery.  268:403-407. 2018
    2018 How academically productive are endocrine surgeons in the United States?Journal of Surgical Research.  229:122-126. 2018
    2018 Hyperthyroidism is Underdiagnosed and Undertreated in 3336 Patients: An Opportunity for Improvement and InterventionAnnals of Surgery.  268:506-512. 2018
    2018 Reducing cost and improving operating room efficiency: examination of surgical instrument processingJournal of Surgical Research.  229:15-19. 2018
    2018 Selecting post-acute care settings after abdominal surgery: Are we getting it right?American Journal of Surgery.  216:260-266. 2018
    2018 The Role of Notch3 in CancerOncologist.  23:900-911. 2018
    2018 The effects of tenure and promotion on surgeon productivityJournal of Surgical Research.  227:67-71. 2018
    2018 Wide variation in cost of surgical care for parathyroidectomy: is there a need for standardization of practice?Surgery.  163:638-642. 2018
    2018 Editorial: The phantom menace: implications of polyclonality for surgical treatment of primary hyperparathyroidismSurgery.  163:15-16. 2018
    2018 Notch3 as a novel therapeutic target in metastatic medullary thyroid cancerSurgery.  163:104-111. 2018
    2018 Racial disparities in the cost of surgical care for parathyroidectomyJournal of Surgical Research.  221:216-221. 2018
    2017 Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomasNature Communications.  8. 2017
    2017 Failure to Diagnose Hyperparathyroidism in 10,432 Patients with HypercalcemiaAnnals of Surgery.  266:632-640. 2017
    2017 MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinomaExperimental and Molecular Pathology.  103:229-236. 2017
    2017 Reduced disparities and improved surgical outcomes for Asian Americans with colorectal cancerJournal of Surgical Research.  218:23-28. 2017
    2017 Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1Cancer Medicine.  6:2142-2152. 2017
    2017 The Association for Academic Surgeons 2001-2010: a decade of inclusivenessJournal of Surgical Research.  217:16-19. 2017
    2017 Encapsulated follicular variant of papillary thyroid cancer: are these tumors really benign?Journal of Surgical Research.  216:138-142. 2017
    2017 Optimizing Outpatient Pain Management After Thyroid and Parathyroid Surgery: A Two-Institution ExperienceAnnals of Surgical Oncology.  24:1951-1957. 2017
    2017 Neuroendocrine Tumors of the StomachSurgical Clinics of North America.  97:333-343. 2017
    2017 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the PostpartumThyroid.  27:315-389. 2017
    2017 Intraoperative Parathyroid Hormone Levels at 5 min Can Identify Multigland DiseaseAnnals of Surgical Oncology.  24:733-738. 2017
    2017 Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosisCancer.  123:769-782. 2017
    2017 Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence ImagingAdvanced Materials for Optics and Electronics.  27. 2017
    2017 Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and MigrationScientific Reports.  7. 2017
    2017 AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatmentJournal of Materials Chemistry B.  5:151-159. 2017
    2017 Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypesOncotarget.  8:24457-24468. 2017
    2017 Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivoOncotarget.  8:70828-70840. 2017
    2017 How long should we follow patients after apparently curative parathyroidectomy?Surgery.  161:54-61. 2017
    2017 Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?Journal of Surgical Research.  207:235-240. 2017
    2017 The Epstein-Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferationSurgery.  161:195-201. 2017
    2017 The changing pattern of diagnosing primary hyperparathyroidism in young patientsAmerican Journal of Surgery.  213:146-150. 2017
    2016 The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoidsCancer Gene Therapy.  23:348-354. 2016
    2016 Thyroidectomy for Graves’ disease in children: Indications and complicationsJournal of Pediatric Surgery.  51:1680-1683. 2016
    2016 Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid ProceduresAnnals of Surgical Oncology.  23:2874-2882. 2016
    2016 Hands-on training in the operating room as a method of continuing education for surgeons in practiceJAMA Surgery.  151:869-870. 2016
    2016 KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapyBiomaterials.  97:22-33. 2016
    2016 Postacute care after major abdominal surgery in elderly patients intersection of age, functional status, and postoperative complicationsJAMA Surgery.  151:759-766. 2016
    2016 Notch1 signaling regulates the aggressiveness of differentiated thyroid cancer and inhibits SERPINE1 expressionClinical Cancer Research.  22:3582-3592. 2016
    2016 A phase II trial of a histone deacetylase inhibitor panobinostat in patients with low-grade neuroendocrine tumorsOncologist.  21:785-786. 2016
    2016 Should Vitamin D deficiency be corrected before parathyroidectomy?Journal of Surgical Research.  204:94-100. 2016
    2016 Generation of Novel Thyroid Cancer Stem-Like Cell Clones Effects of Resveratrol and Valproic AcidAmerican Journal of Pathology.  186:1662-1673. 2016
    2016 Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapyBiomaterials.  91:1-10. 2016
    2016 When patients call their surgeon's office: An opportunity to improve the quality of surgical care and prevent readmissionsAmerican Journal of Surgery.  211:599-604. 2016
    2016 Compromised Outcome of Papillary Thyroid Cancer at Low-Volume Treatment Centers: Practice Makes Perfect?Annals of Surgical Oncology.  23:355-357. 2016
    2016 Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantationSurgery.  159:172-180. 2016
    2016 Primary hyperparathyroidismUlusal cerrahi dergisi.  32:58-66. 2016
    2016 Prospective Intervention of a Novel Levothyroxine Dosing Protocol Based on Body Mass Index after Thyroidectomy Presented at the American College of Surgeons 100th Annual Clinical Congress, San Francisco, CA, October 2014.Journal of The American College of Surgeons.  222:83-88. 2016
    2015 Adenomas of cervical maldescended parathyroid glands: Pearls and pitfallsAustralian and New Zealand Journal of Surgery.  85:957-961. 2015
    2015 Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidismJournal of Surgical Research.  199:115-120. 2015
    2015 Substernal goiter: When is a sternotomy required?Journal of Surgical Research.  199:121-125. 2015
    2015 Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoidsCancer Gene Therapy.  22:496-505. 2015
    2015 Does levothyroxine administration impact parathyroid localization?Journal of Surgical Research.  198:360-365. 2015
    2015 Thyroglobulin antibody resolution after total thyroidectomy for cancerJournal of Surgical Research.  198:366-370. 2015
    2015 Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiationCancer Gene Therapy.  22:410-416. 2015
    2015 Hypoparathyroidism after total thyroidectomy: Incidence and resolutionJournal of Surgical Research.  197:348-353. 2015
    2015 Radioguided parathyroidectomy for tertiary hyperparathyroidismJournal of Surgical Research.  195:406-411. 2015
    2015 Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ DiseaseAnnals of Surgical Oncology.  22:1196-1199. 2015
    2015 Outcomes After Subtotal Parathyroidectomy for Primary Hyperparathyroidism due to Hyperplasia: Significance of Whole vs. Partial Gland RemnantAnnals of Surgical Oncology.  22:966-971. 2015
    2015 Tumor-suppressor role of notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological inductionMolecular Cancer Therapeutics.  14:499-512. 2015
    2015 All Thyroid Ultrasound Evaluations are Not Equal: Sonographers Specialized in Thyroid Cancer Correctly Label Clinical N0 Disease in Well Differentiated Thyroid CancerAnnals of Surgical Oncology.  22:422-428. 2015
    2015 CaPTHUS Scoring Model in Primary Hyperparathyroidism: Can It Eliminate the Need for ioPTH Testing?Annals of Surgical Oncology.  22:1191-1195. 2015
    2015 Chasing Calcitonin: Reoperations for Medullary Thyroid CarcinomaAnnals of Surgical Oncology.  22:7-8. 2015
    2015 Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesisOncotarget.  6:12080-12093. 2015
    2015 Do additional imaging studies change operative management in patients undergoing adrenalectomy? Presented at Central Surgical Association, Chicago, IL March 2015.Surgery.  158:1003-1011. 2015
    2015 Evaluation and management of the pediatric thyroid noduleOncologist.  20:19-27. 2015
    2015 How well does renal transplantation cure hyperparathyroidism?Annals of Surgery.  262:653-659. 2015
    2015 Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate?American Journal of Surgery.  209:483-487. 2015
    2015 Justified Follow-Up: A Final Intraoperative Parathyroid Hormone (ioPTH) Over 40 pg/mL is Associated with an Increased Risk of Persistence and Recurrence in Primary HyperparathyroidismAnnals of Surgical Oncology.  22:454-459. 2015
    2015 Lymph Node Metastases do not Impact Survival in Follicular Variant Papillary Thyroid CancerAnnals of Surgical Oncology.  22:158-163. 2015
    2015 Preventing Postoperative Hypocalcemia in Patients with Graves Disease: A Prospective StudyAnnals of Surgical Oncology.  22:952-958. 2015
    2015 Surgery: Papillary thyroid cancer-how aggressive should surgery be?Nature Reviews Endocrinology.  11:195-196. 2015
    2014 A survey of preferences regarding surgical approach to thyroid surgeryWorld Journal of Surgery.  38:696-703. 2014
    2014 Improvement of sleep disturbance and insomnia following parathyroidectomy for primary hyperparathyroidismWorld Journal of Surgery.  38:542-548. 2014
    2014 Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burdenJournal of Surgical Research.  187:1-5. 2014
    2014 Predictors of recurrence in primary hyperparathyroidism: An analysis of 1386 casesAnnals of Surgery.  259:563-568. 2014
    2014 Hypothyroidism after a cancer diagnosis: Etiology, diagnosis, complications, and managementOncologist.  19:34-43. 2014
    2014 An intact parathyroid hormone-based protocol for the prevention and treatment of symptomatic hypocalcemia after thyroidectomyJournal of Surgical Research.  186:23-28. 2014
    2014 Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastasesAustralian and New Zealand Journal of Surgery.  84:240-244. 2014
    2014 Distinguishing classical papillary thyroid microcancers from follicular-variant microcancersJournal of Surgical Research.  190:151-156. 2014
    2014 Elevated parathyroid hormone after parathyroidectomy delays symptom improvementJournal of Surgical Research.  190:119-125. 2014
    2014 Failure of Radioactive Iodine in the Treatment of HyperthyroidismAnnals of Surgical Oncology.  21:4174-4180. 2014
    2014 Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid CancerAnnals of Surgical Oncology.  21:497-504. 2014
    2014 Identifying predictors of a difficult thyroidectomyJournal of Surgical Research.  190:157-163. 2014
    2014 Is central lymph node dissection necessary for parathyroid carcinoma?Surgery.  156:1336-1341. 2014
    2014 Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: A two-institution analysis of more than 2,000 patientsSurgery.  156:760-768. 2014
    2014 Novel approaches in anaplastic thyroid cancer therapyOncologist.  19:1148-1155. 2014
    2014 Novel thyroidectomy difficulty scale correlates with operative timesWorld Journal of Surgery.  38:1984-1989. 2014
    2014 Parathyroid conditions in childhoodSeminars in Pediatric Surgery.  23:66-70. 2014
    2014 Postoperative surveillance of small appendiceal carcinoid tumorsAmerican Journal of Surgery.  207:342-345. 2014
    2014 Primary hyperparathyroidism across the ages: Presentation and outcomesJournal of Surgical Research.  190:185-190. 2014
    2014 Radioactive iodine remnant uptake after completion thyroidectomy: Not such a complete cancer operationAnnals of Surgical Oncology.  21:1379-1383. 2014
    2014 Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomasJournal of Surgical Research.  190:198-202. 2014
    2014 Role of cervical ultrasound in detecting thyroid pathology in primary hyperparathyroidismJournal of Surgical Research.  190:575-578. 2014
    2014 Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growthCancer Biology and Therapy.  15:510-515. 2014
    2014 Surgeon and Staff Radiation Exposure During Radioguided Parathyroidectomy at a High-Volume InstitutionAnnals of Surgical Oncology.  21:3853-3858. 2014
    2014 Surgical site infection after thyroidectomy: A rare but significant complicationJournal of Surgical Research.  190:170-176. 2014
    2014 The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomySurgery.  156:1308-1314. 2014
    2014 The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growthJournal of Surgical Research.  190:191-197. 2014
    2014 The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progressionAmerican Journal of Pathology.  184:2342-2354. 2014
    2014 Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivoCancer Gene Therapy.  21:518-525. 2014
    2014 Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidismAnnals of Surgical Oncology.  21:2303-2309. 2014
    2013 A multi-institutional international study of risk factors for hematoma after thyroidectomySurgery.  154:1283-1291. 2013
    2013 The role of epithelial mesenchymal transition markers in thyroid carcinoma progressionEndocrine Pathology.  24:206-212. 2013
    2013 Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidismSurgery.  154:1463-1469. 2013
    2013 Leflunomide suppresses growth in human medullary thyroid cancer cellsJournal of Surgical Research.  185:212-216. 2013
    2013 MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through akt inhibitionAnnals of Surgical Oncology.  20:3862-3868. 2013
    2013 New developments in the diagnosis and treatment of thyroid cancerCA: A Cancer Journal for Clinicians.  63:374-394. 2013
    2013 Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapyNanoscale.  5:9924-9933. 2013
    2013 The Role of Cdk5 in Neuroendocrine Thyroid CancerCancer Cell.  24:499-511. 2013
    2013 Follicular variant of papillary thyroid carcinoma is a unique clinical entity: A population-based study of 10,740 casesThyroid.  23:1263-1268. 2013
    2013 Nondiagnostic fine-needle aspirations of the thyroid: Is the risk of malignancy higher?Journal of Surgical Research.  184:746-750. 2013
    2013 Remnant uptake as a postoperative oncologic quality indicatorThyroid.  23:1269-1276. 2013
    2013 The incidence of thyroid cancer by f ine needle aspiration varies by age and genderJournal of Surgical Research.  184:761-765. 2013
    2013 Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identifiedAnnals of Surgical Oncology.  20:4200-4204. 2013
    2013 Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidismAnnals of Surgical Oncology.  20:4205-4211. 2013
    2013 Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenariansAnnals of Surgical Oncology.  20:4195-4199. 2013
    2013 Parathyroid cryopreservation after parathyroidectomy: A worthwhile practice?Annals of Surgical Oncology.  20:2256-2260. 2013
    2013 Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growthMolecular Cancer Therapeutics.  12:1276-1287. 2013
    2013 Erratum: Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro (Anti-Cancer Drugs (2013) 24 (66-72))Anti-Cancer Drugs.  24:658. 2013
    2013 Impact of lymph node ratio on survival in papillary thyroid cancerAnnals of Surgical Oncology.  20:1906-1911. 2013
    2013 Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinomaJournal of The American College of Surgeons.  216:1174-1180. 2013
    2013 Consensus guidelines for the management and treatment of neuroendocrine tumorsPancreas.  42:557-577. 2013
    2013 Doing away with the rule of 10 %Annals of Surgical Oncology.  20:1403-1404. 2013
    2013 Hereditary medullary thyroid cancer: Age-appropriate thyroidectomy improves disease-free survivalAnnals of Surgical Oncology.  20:1451-1455. 2013
    2013 Role of postoperative vitamindand/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy:Asystematic review and meta-analysisOncologist.  18:533-542. 2013
    2013 Lymph node ratio predicts recurrence in papillary thyroid cancerOncologist.  18:157-162. 2013
    2013 Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidismAmerican Journal of Surgery.  205:269-273. 2013
    2013 Synergistic effect of pasireotide and teriflunomide in carcinoids in vitroNeuroendocrinology.  97:183-192. 2013
    2013 Using body mass index to predict optimal thyroid dosing after thyroidectomyJournal of The American College of Surgeons.  216:454-460. 2013
    2013 Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivoCancer.  119:774-781. 2013
    2013 Utility of 111indium-pentetreotide scintigraphy in patients with neuroendocrine tumorsAnnals of Surgical Oncology.  20:640-645. 2013
    2013 A short-stay unit for thyroidectomy patients increases discharge efficiencyJournal of Surgical Research.  184:204-208. 2013
    2013 Cancer after thyroidectomy: A multi-institutional experience with 1,523 patientsJournal of The American College of Surgeons.  216:571-577. 2013
    2013 Clinicopathologic characteristics of colonic carcinoid tumorsJournal of Surgical Research.  184:183-188. 2013
    2013 Creation of a "wisconsin Index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomyAnnals of Surgery.  257:138-141. 2013
    2013 Current understanding and management of medullary thyroid cancerOncologist.  18:1093-1100. 2013
    2013 Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomasModern Pathology.  26:54-61. 2013
    2013 Incidence and localization of ectopic parathyroid adenomas in previously unexplored patientsWorld Journal of Surgery.  37:102-106. 2013
    2013 Increased efficiency of endocrine procedures performed in an ambulatory operating roomJournal of Surgical Research.  184:200-203. 2013
    2013 Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitroAnti-Cancer Drugs.  24:66-72. 2013
    2013 Radioactive iodine scanning is not beneficial but its use persists for euthyroid patientsJournal of Surgical Research.  184:269-273. 2013
    2013 Radioguided parathyroidectomy effective in pediatric patientsJournal of Surgical Research.  184:312-317. 2013
    2013 Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and NotchNeuroendocrinology.  97:57-66. 2013
    2013 Significance of rebounding parathyroid hormone levels during parathyroidectomyJournal of Surgical Research.  184:265-268. 2013
    2013 Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell lineCancer Medicine.  2:734-743. 2013
    2013 Unilateral thyroidectomy for the treatment of benign multinodular goiterJournal of Surgical Research.  184:514-518. 2013
    2012 Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapyNanoscale.  4:7185-7193. 2012
    2012 Intrathyroidal parathyroid glands: Small, but mighty (a Napoleon phenomenon)Surgery.  152:1193-1200. 2012
    2012 Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 casesSurgery.  152:1008-1015. 2012
    2012 Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy?Surgery.  152:1211-1217. 2012
    2012 Is thyroidectomy in patients with Hashimoto thyroiditis more risky?Journal of Surgical Research.  178:529-532. 2012
    2012 Same-day thyroidectomy program: Eligibility and safety evaluationSurgery.  152:1133-1141. 2012
    2012 Symptoms of gastroesophageal reflux disease improve after parathyroidectomySurgery.  152:1232-1237. 2012
    2012 Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: A prospective cohort studyOncologist.  17:1271-1276. 2012
    2012 Incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgeryJournal of Surgical Research.  178:264-267. 2012
    2012 Routine chest X-ray prior to thyroid surgery: Is it always necessary?World Journal of Surgery.  36:2584-2589. 2012
    2012 Sestamibi imaging for primary hyperparathyroidism: The impact of surgeon interpretation and radiologist volumeAnnals of Surgical Oncology.  19:3827-3831. 2012
    2012 Thyroidectomy decreases snoring and sleep apnea symptomsThyroid.  22:1160-1164. 2012
    2012 Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: Weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systemsJournal of Surgical Research.  177:241-247. 2012
    2012 Surveillance of small rectal carcinoid tumors in the absence of metastatic diseaseAnnals of Surgical Oncology.  19:3486-3490. 2012
    2012 Current Treatment of Papillary Thyroid MicrocarcinomaAdvances in Surgery.  46:191-203. 2012
    2012 Safety and feasibility of laparoscopic resection for large (≥6 cm) pheochromocytomas without suspected malignancyEndocrine Practice.  18:720-726. 2012
    2012 The role of gender in primary hyperparathyroidism: Same disease, different presentationAnnals of Surgical Oncology.  19:2958-2962. 2012
    2012 No need to abandon unilateral parathyroid surgeryJournal of The American College of Surgeons.  215:297. 2012
    2012 "Doctor, my thyroid is choking me": Common sense and scientific inquiryArchives of Surgery -New York-.  147:626. 2012
    2012 Sestamibi-negative patients: To operate or image?Annals of Surgical Oncology.  19:2086-2087. 2012
    2012 Does the final intraoperative PTH level really have to fall into the normal range to signify cure?Annals of Surgical Oncology.  19:1862-1867. 2012
    2012 Are there predictors of malignancy in patients with multinodular goiter?Journal of Surgical Research.  174:207-210. 2012
    2012 Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancerEndocrine Practice.  18:403-409. 2012
    2012 What is the Utility of distal forearm DXA in primary Hyperparathyroidism?Oncologist.  17:322-325. 2012
    2012 Is focused minimally invasive parathyroidectomy appropriate for patients with familial primary hyperparathyroidism?Annals of Surgical Oncology.  19:1264-1268. 2012
    2012 Breast radiation correlates with side of parathyroid adenomaWorld Journal of Surgery.  36:607-611. 2012
    2012 False-negative fine-needle aspiration of thyroid nodules cannot be attributed to sampling error aloneAmerican Journal of Surgery.  203:331-334. 2012
    2012 Hürthle cell metaplasia on fine-needle aspiration biopsy is not by itself an indication for thyroid surgeryAmerican Journal of Surgery.  203:287-291. 2012
    2012 Presurgical localization of parathyroid adenomas with magnetic resonance imaging at 3.0 T: An adjunct method to supplement traditional imagingAnnals of Surgical Oncology.  19:981-989. 2012
    2012 The necessity and reliability of intraoperative parathyroid hormone (PTH) Testing in patients with mild hyperparathyroidism and PTH levels in the normal range: ReplyWorld Journal of Surgery.  36:484-485. 2012
    2012 Authors' reply: Controversy on papillary thyroid microcarcinoma managementNature Reviews Endocrinology.  8:9. 2012
    2012 Erratum: Advances in surgical therapy for thyroid cancer (Nature Reviews Endocrinology (2011) 7 (581-588) DOI: 10.1038/nrendo.2011.140)Nature Reviews Endocrinology.  8:2. 2012
    2012 Evolution of pediatric thyroid surgery at a tertiary medical centerJournal of Surgical Research.  177:268-274. 2012
    2012 In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive diseaseThyroid.  22:3-8. 2012
    2012 Three large, functioning cystic parathyroid adenomasEndocrine Practice.  18. 2012
    2011 Limitations of the ACS NSQIP in thyroid surgeryAnnals of Surgical Oncology.  18:3529-3530. 2011
    2011 Expression of the active notch1 decreases MTC tumor growth in vivoJournal of Surgical Research.  171:23-27. 2011
    2011 Reply: A rising ioPTH level immediately after parathyroid resection: Are additional hyperfunctioning glands always present? An application of the wisconsin criteriaAnnals of Surgery.  254:671. 2011
    2011 Should all papillary thyroid microcarcinomas be aggressively treated?: An analysis of 18,445 casesAnnals of Surgery.  254:653-660. 2011
    2011 Antiproliferative effect of chrysin on anaplastic thyroid cancerJournal of Surgical Research.  170:84-88. 2011
    2011 Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?Journal of The American College of Surgeons.  213:410-414. 2011
    2011 Fine needle aspiration of the thyroid: A contemporary experience of 3981 casesJournal of Surgical Research.  170:48-51. 2011
    2011 Influence of Surgical Volume on Operative Failures for HyperparathyroidismAdvances in Surgery.  45:237-248. 2011
    2011 Infrared thermographic profiles of vessel sealing devices on thyroid parenchymaJournal of Surgical Research.  170:64-68. 2011
    2011 Should patients with symptomatic Hashimoto's thyroiditis pursue surgery?Journal of Surgical Research.  170:52-55. 2011
    2011 The necessity and reliability of intraoperative parathyroid hormone (PTH) testing in patients with mild hyperparathyroidism and PTH levels in the normal rangeWorld Journal of Surgery.  35:2006-2009. 2011
    2011 Does previous head and neck irradiation increase the chance of multigland disease in patients with hyperparathyroidism?Annals of Surgical Oncology.  18:2240-2244. 2011
    2011 A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinomaOncologist.  16:835-843. 2011
    2011 Sometimes less is moreArchives of Surgery -New York-.  146:710. 2011
    2011 Total thyroidectomy: A safe and effective treatment for Graves' diseaseJournal of Surgical Research.  168:1-4. 2011
    2011 A preclinical and clinical study of lithium in low-grade neuroendocrine tumorsOncologist.  16:452-457. 2011
    2011 Inadequate cytology of thyroid nodules. Repeat it or live with itAnnals of Surgical Oncology.  18:1222-1223. 2011
    2011 Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancerAnnals of Surgical Oncology.  18:1506-1511. 2011
    2011 Identification and validation of Notch pathway activating compounds through a novel high-throughput screening methodCancer.  117:1386-1398. 2011
    2011 Is there still a glass ceiling for women in academic surgery?Annals of Surgery.  253:637-643. 2011
    2011 Hesperetin, a potential therapy for carcinoid cancerAmerican Journal of Surgery.  201:329-333. 2011
    2011 Intraoperative adjuncts for parathyroid surgeryExpert Review of Endocrinology and Metabolism.  6:245-253. 2011
    2011 A comparison of the ligasure and harmonic scalpel in thyroid surgery: A single institution reviewAnnals of Surgical Oncology.  18:214-218. 2011
    2011 Advances in surgical therapy for thyroid cancerNature Reviews Endocrinology.  7:581-588. 2011
    2011 What is the added benefit of cervical ultrasound to 99mTc- sestamibi scanning in primary hyperparathyroidism?Annals of Surgical Oncology.  18:2907-2911. 2011
    2010 In BriefCurrent Problems in Surgery.  47:954-956. 2010
    2010 New Trends in Parathyroid SurgeryCurrent Problems in Surgery.  47:958-1017. 2010
    2010 Signaling mechanisms in neuroendocrine tumors as targets for therapyEndocrinology and Metabolism Clinics of North America.  39:801-810. 2010
    2010 25-Hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidismAnnals of Surgical Oncology.  17:2958-2962. 2010
    2010 Response to "response to: Tertiary hyperparathyroidism: Is less than a subtotal resection ever appropriate? A study on long-term outcomes"Surgery.  148:1045. 2010
    2010 DiscussionsAnnals of Surgery.  252:651. 2010
    2010 Does routine use of ultrasound result in additional thyroid procedures in patients with primary hyperparathyroidism?Journal of The American College of Surgeons.  211:536-539. 2010
    2010 Operative failures after parathyroidectomy for hyperparathyroidism: The influence of surgical volumeAnnals of Surgery.  252:691-694. 2010
    2010 Postoperative parathyroid hormone testing decreases symptomatic hypocalcemia and associated emergency room visits after total thyroidectomySurgery.  148:841-846. 2010
    2010 MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targetsEndocrine-Related Cancer.  17:835-846. 2010
    2010 Parathyroid hormone deficiency after total thyroidectomy: Incidence and timeJournal of Surgical Research.  163:69-71. 2010
    2010 Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoidsInternational Journal of Clinical and Experimental Medicine.  3:95-102. 2010
    2010 The north american neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancerPancreas.  39:775-783. 2010
    2010 Lithium inhibits carcinoid cell growth in vitroAmerican Journal of Translational Research.  2:248-253. 2010
    2010 Is endocrine surgery research dying?American Journal of Translational Research.  2:129-134. 2010
    2010 A rising IoPTH level immediately after parathyroid resection: Are additional hyperfunctioning glands always present? an application of the wisconsin criteriaAnnals of Surgery.  251:1127-1130. 2010
    2010 Diagnostic utility of fine-needle aspiration cytology in pediatric differentiated thyroid cancerWorld Journal of Surgery.  34:1254-1260. 2010
    2010 Secondary and tertiary hyperparathyroidism: The utility of ioPTH monitoringWorld Journal of Surgery.  34:1343-1349. 2010
    2010 Thyroid hormone replacement in women of reproductive age: Is surgeon knowledge related to operative volume?Thyroid.  20:627-631. 2010
    2010 ZM336372 Induces Apoptosis Associated with Phosphorylation of GSK-3β in Pancreatic Adenocarcinoma Cell LinesJournal of Surgical Research.  161:28-32. 2010
    2010 Clinical Efficacy of Fine-Needle Aspiration Biopsy of Thyroid Nodules in MalesJournal of Surgical Research.  159:645-650. 2010
    2010 Inhibition of Growth in Medullary Thyroid Cancer Cells with Histone Deacetylase Inhibitors and Lithium ChlorideJournal of Surgical Research.  159:640-644. 2010
    2010 Influence of morbid obesity on parathyroidectomy outcomes in primary hyperparathyroidismAmerican Journal of Surgery.  199:410-415. 2010
    2010 Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancerAmerican Journal of Surgery.  199:315-318. 2010
    2010 Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancerAmerican Journal of Translational Research.  2:119-125. 2010
    2010 Multi-targeted approach in the treatment of thyroid cancerMinerva Chirurgica.  65:59-69. 2010
    2010 Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cellsCell Growth and Differentiation.  8:775-782. 2010
    2010 Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growthMolecular Cancer Therapeutics.  9:429-437. 2010
    2010 Is DVT prophylaxis necessary for thyroidectomy and parathyroidectomy?Surgery.  148:1163-1169. 2010
    2010 MG-132 Inhibits Carcinoid Growth and Alters the Neuroendocrine PhenotypeJournal of Surgical Research.  158:15-19. 2010
    2010 Training our future endocrine surgeons: A look at the endocrine surgery operative experience of U.S. surgical residentsSurgery.  148:1075-1081. 2010
    2010 What is the optimal treatment for children with primary hyperparathyroidism?Journal of Pediatric Surgery.  45:1142-1146. 2010
    2009 Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancerThyroid.  19:1373-1380. 2009
    2009 Medullary thyroid carcinoma: Targeted therapies and future directionsJournal of Oncology2009
    2009 Neurocognitive dysfunction: A predictor of parathyroid hyperplasiaSurgery.  146:1138-1143. 2009
    2009 Role of menin in neuroendocrine tumorigenesisAdvances in Experimental Medicine and Biology.  668:87-95. 2009
    2009 Tertiary hyperparathyroidism: Is less than a subtotal resection ever appropriate? A study of long-term outcomesSurgery.  146:1130-1137. 2009
    2009 Utility of intraoperative PTH for primary hyperparathyroidism due to multigland diseaseAnnals of Surgical Oncology.  16:3450-3454. 2009
    2009 Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cellsWorld Journal of Surgery.  33:2452-2457. 2009
    2009 Nonoperative management of primary hyperparathyroidism: The exception rather than the ruleExpert Review of Endocrinology and Metabolism.  4:553-563. 2009
    2009 Papillary thyroid microcarcinomas: Big decisions for a small tumorAnnals of Surgical Oncology.  16:3132-3139. 2009
    2009 Association for Academic Surgery Presidential Address Episode VI: The Return of the Surgeon1Journal of Surgical Research.  156:333-339. 2009
    2009 Inhibition of phosphatidylinositol 3-kinase/akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumorsAnnals of Surgical Oncology.  16:2936-2942. 2009
    2009 Radioguided parathyroidectomy for hyperparathyroidism in the reoperative neckSurgery.  146:592-599. 2009
    2009 Secondary and Tertiary Hyperparathyroidism, State of the Art Surgical ManagementSurgical Clinics of North America.  89:1227-1239. 2009
    2009 Thyroid hormone replacement after thyroid lobectomySurgery.  146:554-560. 2009
    2009 AKT and PTEN expression in human gastrointestinal carcinoid tumorsAmerican Journal of Translational Research.  1:291-299. 2009
    2009 Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinomaAmerican Journal of Translational Research.  1:358-366. 2009
    2009 Follicular Thyroid Cancer Cell Growth Inhibition By Proteosome Inhibitor MG1321Journal of Surgical Research.  156:39-44. 2009
    2009 Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extensionClinical Endocrinology.  71:434-439. 2009
    2009 Outcomes of Surgically Managed Pediatric Thyroid CancerJournal of Surgical Research.  156:70-73. 2009
    2009 Revisiting Adrenal Mass Size as an Indication for AdrenalectomyJournal of Surgical Research.  156:16-20. 2009
    2009 Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytomaAmerican Journal of Translational Research.  1:178-183. 2009
    2009 Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or largerArchives of Surgery -New York-.  144:649-654. 2009
    2009 Phosphatidylinositol 3-Kinase-Akt Signaling in Pulmonary Carcinoid CellsJournal of The American College of Surgeons.  209:82-88. 2009
    2009 The effectiveness of radioguided parathyroidectomy in patients with negative technetium Tc 99m-sestamibi scansArchives of Surgery -New York-.  144:643-647. 2009
    2009 ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: A case report and review of the literatureWorld Journal of Surgical Oncology.  7. 2009
    2009 Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3βMolecular Cancer Therapeutics.  8:914-920. 2009
    2009 Contralateral papillary thyroid cancer: does size matter?American Journal of Surgery.  197:342-347. 2009
    2009 Surgery improves quality of life in patients with "mild" hyperparathyroidismAmerican Journal of Surgery.  197:284-290. 2009
    2009 Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathwayAmerican Journal of Surgery.  197:313-319. 2009
    2009 What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?Annals of Surgery.  249:469-472. 2009
    2009 Combination therapy with histone deacetylase inhibitors and lithium chloride: A novel treatment for carcinoid tumorsAnnals of Surgical Oncology.  16:481-486. 2009
    2009 Laryngeal complications after thyroidectomy-invited critiqueArchives of Surgery -New York-.  144:153. 2009
    2009 Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitorsMolecular Cancer Therapeutics.  8:350-356. 2009
    2009 Thyroid resection improves perception of swallowing function in patients with thyroid diseaseWorld Journal of Surgery.  33:255-260. 2009
    2008 Carcinoid tumorsOncologist.  13:1255-1269. 2008
    2008 Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cellsSurgery.  144:956-962. 2008
    2008 Multi-targeted approach in the treatment of thyroid cancerTherapeutics and Clinical Risk Management.  4:935-947. 2008
    2008 Principles of minimally invasive parathyroidectomyCurrent Medical Imaging Reviews.  4:250-254. 2008
    2008 Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathwaySurgery.  144:920-925. 2008
    2008 Is Hashimoto's Thyroiditis a Risk Factor for Papillary Thyroid Cancer?Journal of Surgical Research.  150:49-52. 2008
    2008 Preserving function and quality of life after thyroid and parathyroid surgeryLancet Oncology.  9:1069-1075. 2008
    2008 The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancerSurgery.  144:721-724. 2008
    2008 Older age and larger tumor size predict malignancy in Hürthle cell neoplasms of the thyroidAnnals of Surgical Oncology.  15:2842-2846. 2008
    2008 Radioguided reoperative parathyroidectomy for persistent primary hyperparathyroidismClinical Nuclear Medicine.  33:668-670. 2008
    2008 Suberoyl bishydroxamic acid activates Notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinomaAnnals of Surgical Oncology.  15:2600-2605. 2008
    2008 Pheochromocytoma: Current approaches and future directionsOncologist.  13:779-793. 2008
    2008 Valproic Acid Induces Notch1 Signaling in Small Cell Lung Cancer CellsJournal of Surgical Research.  148:31-37. 2008
    2008 Are Surgical Progeny More Likely to Pursue a Surgical Career?Journal of Surgical Research.  147:253-259. 2008
    2008 Incisions and Exposure of the Neck for Thyroidectomy and ParathyroidectomyOperative Techniques in General Surgery.  10:63-76. 2008
    2008 Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumorsCurrent Opinion in Investigational Drugs.  9:576-582. 2008
    2008 The influence of surgical approach on quality of life after parathyroid surgeryAnnals of Surgical Oncology.  15:1559-1565. 2008
    2008 Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cellsAnnals of Surgery.  247:1036-1040. 2008
    2008 Current management of medullary thyroid cancerOncologist.  13:539-547. 2008
    2008 ZM336372, A Raf-1 Activator, Causes Suppression of Proliferation in a Human Hepatocellular Carcinoma Cell LineJournal of Gastrointestinal Surgery.  12:852-857. 2008
    2008 The role of intraoperative frozen section if suspicious for papillary thyroid cancerThyroid.  18:419-423. 2008
    2008 The use of the Ligasure for hemostasis during thyroid lobectomyAmerican Journal of Surgery.  195:382-385. 2008
    2008 The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytomaAnnals of Surgical Oncology.  15:900-905. 2008
    2008 Therapeutic options for patients with metastatic gastrointestinal carcinoidJournal of Surgical Oncology.  97:203-204. 2008
    2008 Pre-operative management of patients with Graves' diseaseSurgery.  143:292-293. 2008
    2008 Suberoyl bis-hydroxamic acid activates notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cellsOncologist.  13:98-104. 2008
    2008 Author reply [2]Annals of Surgical Oncology.  15:380-381. 2008
    2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stageJournal of Clinical Endocrinology and Metabolism.  93:809-814. 2008
    2007 Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathwaysSurgery.  142:959-964. 2007
    2007 Palliation of advanced thyroid malignanciesSurgical Oncology.  16:237-247. 2007
    2007 Computed tomography in the diagnosis of acute appendicitis: Definitive or detrimental?Journal of Gastrointestinal Surgery.  11:1417-1422. 2007
    2007 Incidental carcinoid tumors of the appendix: Do they affect presentation or prognosis?International Surgery.  92:331-334. 2007
    2007 Motivation to Pursue Surgical Subspecialty Training: Is There a Gender Difference?Journal of The American College of Surgeons.  205:698-703. 2007
    2007 Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cellsJournal of Gastrointestinal Surgery.  11:1515-1520. 2007
    2007 Tumor suppressor role of notch-1 signaling in neuroendocrine tumorsOncologist.  12:535-542. 2007
    2007 Symptomatic benign multinodular goiter: Unilateral or bilateral thyroidectomy?Surgery.  142:458-462. 2007
    2007 The HDAC Inhibitor Trichostatin A Inhibits Growth of Small Cell Lung Cancer CellsJournal of Surgical Research.  142:219-226. 2007
    2007 Isolated adrenal mass in patients with a history of cancer: Remember pheochromocytomaAnnals of Surgical Oncology.  14:2358-2362. 2007
    2007 The negative sestamibi scan: Is a minimally invasive parathyroidectomy still possible?Annals of Surgical Oncology.  14:2363-2366. 2007
    2007 Valproic acid activates Notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cellsOncologist.  12:942-951. 2007
    2007 The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testingAnnals of Surgery.  245:959-963. 2007
    2007 Equal Oncologic Results for Laparoscopic and Open Resection of Adrenal MetastasesJournal of Surgical Research.  140:159-164. 2007
    2007 Parathyroidectomy for Primary Hyperparathyroidism in Octogenarians and Nonagenarians: A Risk-Benefit AnalysisJournal of Surgical Research.  140:194-198. 2007
    2007 Radioguided parathyroidectomy for recurrent parathyroid cancerClinical Nuclear Medicine.  32:358-360. 2007
    2007 Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cellsMolecular Cancer Therapeutics.  6:1151-1158. 2007
    2007 Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesionAmerican Journal of Surgery.  193:331-335. 2007
    2007 Lithium ions: A novel treatment for pheochromocytomas and paragangliomasSurgery.  141:161-165. 2007
    2007 Local/cervical block anesthesia versus general anesthesia for minimally invasive parathyroidectomy: What are the advantages?Annals of Surgical Oncology.  14:744-749. 2007
    2007 Radioguided parathyroidectomy in patients with familial hyperparathyroidismAnnals of Surgical Oncology.  14:739-743. 2007
    2007 Consequences of parathyroidectomy in patients with "mild" sporadic primary hyperparathyroidismSurgery.  142:795-799.e2. 2007
    2007 Effective Surgical Residents Strongly Influence Medical Students to Pursue Surgical CareersJournal of The American College of Surgeons.  204:164-167. 2007
    2007 Initial lymph node dissection increases cure rates in patients with medullary thyroid cancerAsian Journal of Surgery.  30:108-112. 2007
    2007 Risks and consequences of incidental parathyroidectomy during thyroid resectionAustralian and New Zealand Journal of Surgery.  77:33-36. 2007
    2007 Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.Translational Oncogenomics.  2:43-47. 2007
    2006 Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cellsJournal of Biological Chemistry.  281:39819-39830. 2006
    2006 Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002Surgery.  140:1009-1015. 2006
    2006 Does Frozen Section Alter Surgical Management of Multinodular Thyroid Disease?Journal of Surgical Research.  136:179-181. 2006
    2006 Ex Vivo Radioactive Counts and Decay Rates of Tissues Resected During Radioguided ParathyroidectomyJournal of Surgical Research.  136:187-191. 2006
    2006 Mitogen-Activated Protein Kinases and Chemoresistance in Pancreatic Cancer CellsJournal of Surgical Research.  136:325-335. 2006
    2006 Is tumor size the best predictor of outcome for papillary thyroid cancer?Annals of Surgical Oncology.  13:1524-1528. 2006
    2006 Metastatic neuroendocrine hepatic tumors: Resection improves survivalArchives of Surgery -New York-.  141:1000-1004. 2006
    2006 In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancerAnti-Cancer Drugs.  17:849-853. 2006
    2006 What is the Biology and Optimal Treatment for Papillary Microcarcinoma of the Thyroid?Journal of Surgical Research.  134:160-162. 2006
    2006 Carcinoid TumorsSurgical Oncology Clinics of North America.  15:463-478. 2006
    2006 PrefaceSurgical Oncology Clinics of North America.  15. 2006
    2006 The Surgical Management of Graves' DiseaseJournal of Surgical Research.  133:207-214. 2006
    2006 A Prospective Evaluation of Novel Methods to Intraoperatively Distinguish Parathyroid Tissue Utilizing a Parathyroid Hormone AssayJournal of Surgical Research.  133:38-41. 2006
    2006 Fine-needle aspiration optimizes surgical management in patients with thyroid cancerAnnals of Surgical Oncology.  13:859-863. 2006
    2006 ZM336372, A Raf-1 Activator, Inhibits Growth of Pheochromocytoma CellsJournal of Surgical Research.  133:42-45. 2006
    2006 Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism - Invited critiqueArchives of Surgery -New York-.  141:134. 2006
    2006 The Raf-1 pathway: A molecular target for treatment of select neuroendocrine tumors?Anti-Cancer Drugs.  17:139-142. 2006
    2006 Calciphylaxis in the absence of end-stage renal diseaseEndocrine Practice.  12:406-410. 2006
    2006 Long-term outcomes in patients with calciphylaxis from hyperparathyroidismAnnals of Surgical Oncology.  13:96-102. 2006
    2006 The need for intraoperative parathyroid hormone monitoring during radioguided parathyroidectomy by Video-Assisted Thoracoscopy (VATS)Clinical Nuclear Medicine.  31:9-12. 2006
    2006 Treatment of advanced carcinoid tumorsCurrent Opinion in Oncology.  18:9-15. 2006
    2006 Treatment of advanced carcinoid tumors.Current Opinion in Oncology.  18:9-15. 2006
    2005 Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cellsSurgery.  138:1137-1142. 2005
    2005 Hyperthyroidism after parathyroid explorationSurgery.  138:1058-1065. 2005
    2005 Intraoperative neurophysiology testing of the recurrent laryngeal nerve: Plaudits and pitfallsSurgery.  138:1183-1192. 2005
    2005 Laparoscopic resection of adrenal cortical carcinoma: A cautionary noteSurgery.  138:1078-1086. 2005
    2005 The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantationSurgery.  138:1066-1071. 2005
    2005 Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cellsSurgery.  138:979-985. 2005
    2005 Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cellsAJP - Gastrointestinal and Liver Physiology.  289. 2005
    2005 Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomySurgery.  138:583-590. 2005
    2005 Radioguided thoracoscopic mediastinal parathyroidectomy with intraoperative parathyroid hormone testingAnnals of Thoracic Surgery.  80:1262-1265. 2005
    2005 A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: Which is most reliable?Annals of Surgery.  242:375-383. 2005
    2005 Changing trends for surgery in elderly patients with hyperparathyroidism at a single institutionJournal of Surgical Research.  127:58-62. 2005
    2005 Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signalingJournal of Clinical Endocrinology and Metabolism.  90:4350-4356. 2005
    2005 How should medical student surgical rotations be structured to optimize education?Journal of Surgical Research.  126:145-148. 2005
    2005 A mouse model of carcinoid syndrome and heart diseaseJournal of Surgical Research.  126:102-105. 2005
    2005 Medullary thyroid cancer: The functions of raf-1 and human achaete-scute homologue-1Thyroid.  15:511-521. 2005
    2005 ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cellsMolecular Cancer Therapeutics.  4:910-917. 2005
    2005 Radioguided techniques for parathyroid surgeryAsian Journal of Surgery.  28:77-81. 2005
    2004 Does propofol anesthesia affect intraoperative parathyroid hormone levels? A randomized, prospective trialSurgery.  136:1138-1142. 2004
    2004 Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cellsSurgery.  136:1297-1302. 2004
    2004 Radioguided parathyroid surgeryAdvances in Surgery.  38:377-392. 2004
    2004 Thallium-pertechnetate subtraction scanning in the preoperative localization of an ectopic undescended parthyroid glandClinical Nuclear Medicine.  29:542-544. 2004
    2004 Does academic advancement impact teaching performance of surgical faculty?Surgery.  136:277-281. 2004
    2004 Chronic abdominal pain and upper gastrointestinal bleeding due to duodenal perforation caused by migrated inferior vena cava filter: A case reportVascular and Endovascular Surgery.  38:381-384. 2004
    2004 Pancreatic endocrine tumorsJournal of Surgical Research.  120:139-161. 2004
    2004 Why do students choose careers in surgery?Journal of Surgical Research.  119:124-129. 2004
    2004 Subclinical Cushing's syndrome in adrenal incidentalomasSurgical Clinics of North America.  84:875-885. 2004
    2004 Gastrointestinal Carcinoid Tumors: Factors that Predict OutcomeWorld Journal of Surgery.  28:387-392. 2004
    2004 Can Thallium-Pertechnetate Subtraction Scanning Play a Role in the Preoperative Imaging for Minimally Invasive Parathyroidectomy?Clinical Nuclear Medicine.  29:21-26. 2004
    2004 Catecholamine excess in pheochromocytoma inducing insulin resistanceEndocrine Practice.  10:149-152. 2004
    2004 The utility of frozen section evaluation for follicular thyroid lesionsAnnals of Surgical Oncology.  11:94-98. 2004
    2003 An update on carcinoid tumorsProblems in General Surgery.  20:125-133. 2003
    2003 Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands.Annals of Surgery.  238:332-337. 2003
    2003 Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cellsAJP - Gastrointestinal and Liver Physiology.  285. 2003
    2003 Radioguided Parathyroidectomy for Recurrent Hyperparathyroidism Caused by Forearm Graft HyperplasiaJournal of Bone and Mineral Research.  18:939-942. 2003
    2003 Utilization of fine-needle aspiration in patients undergoing thyroidectomy at two academic centers across the AtlanticWorld Journal of Surgery.  27:208-211. 2003
    2003 Do the best students go into general surgery?Journal of Surgical Research.  115:69-73. 2003
    2003 Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomySurgery.  134:675-681. 2003
    2003 Medical student operative experience correlates with a match to a categorical surgical programAmerican Journal of Surgery.  186:125-128. 2003
    2003 Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidismSurgery.  134:713-717. 2003
    2003 The role of human achaete-scute homolog-1 in medullary thyroid cancer cellsSurgery.  134:866-871. 2003
    2002 Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiationSurgery.  132:1035-1039. 2002
    2002 Do the national institutes of health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism?Surgery.  132:1013-1020. 2002
    2002 Technique of thymectomy by anterior-superior cervicomediastinal exenterationJournal of The American College of Surgeons.  195:895-900. 2002
    2002 Surgery for primary hyperparathyroidism: What is the best approach?Annals of Surgery.  236:552-553. 2002
    2002 Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenomaAnnals of Surgery.  235:673-680. 2002
    2002 Do future general surgery residents have adequate exposure to endocrine surgery during medical school?World Journal of Surgery.  26:17-21. 2002
    2002 Palliative thyroidectomy for malignant lymphoma of the thyroidAnnals of Surgical Oncology.  9:907-911. 2002
    2002 Primary thyroid lymphoma: Can the diagnosis be made solely by fine-needle aspiration?Annals of Surgical Oncology.  9:298-302. 2002
    2002 Radioguided parathyroidectomy via VATS combined with intraoperative parathyroid hormone testing: The surgical approach of choice for patients with mediastinal parathyroid adenomas?Journal of Bone and Mineral Research.  17:1368-1371. 2002
    2001 Perforated Amyand's HerniaSouthern Medical Journal.  94:496-498. 2001
    2001 Do medical school surgical rotations influence subspecialty choice?Journal of Surgical Research.  97:172-178. 2001
    2001 Endoscopie Transanal Resection Provides Palliation Equivalent to Transabdominal Resection in Patients with Metastatic Rectal CancerJournal of Gastrointestinal Surgery.  5:282-286. 2001
    2001 Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidismSurgery.  130:645-651. 2001
    2000 Use of technetium Tc 99m sestamibi scintigraphy for recurrent tertiary hyperparathyroidism from a parathyroid forearm graftSouthern Medical Journal.  93:215-217. 2000
    2000 General surgery and fellowship training: Opinions of surgical intern applicants and fellowship directorsSurgery.  127:14-18. 2000
    2000 Hepatic Resection Using Intermittent Vascular Inflow Occlusion and Low Central Venous Pressure Anesthesia Improves Morbidity and MortalityJournal of Gastrointestinal Surgery.  4:162-167. 2000
    1999 Anal ultrasound predicts the response to nonoperative treatment of fecal incontinence in menAnnals of Surgery.  229:739-744. 1999
    1999 Clinically significant, isolated metastatic disease to the thyroid glandWorld Journal of Surgery.  23:177-181. 1999
    1999 Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assaySurgery.  126:1016-1022. 1999
    1999 The current management of thyroid cancer.Advances in Surgery.  33:1-27. 1999
    1998 Papillary thyroid carcinoma: Justification for total thyroidectomy and management of lymph node metastasesSurgical Oncology Clinics of North America.  7:645-663. 1998
    1998 Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resectionAnnals of Surgery.  227:887-895. 1998
    1998 Parathyroidectomy in the elderly: Do the benefits outweigh the risks?World Journal of Surgery.  22:531-536. 1998
    1998 Hurthle cell neoplasms of the thyroid: Are there factors predictive of malignancy?Annals of Surgery.  227:542-546. 1998
    1998 Complete Hepatic Resection of Metastases from Leiomyosarcoma Prolongs SurvivalJournal of Gastrointestinal Surgery.  2:151-155. 1998
    1998 Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival?Journal of The American College of Surgeons.  187:88-92. 1998
    1997 The role of fine-needle aspiration in the evaluation of thyroid nodulesProblems in General Surgery.  14:1-13. 1997
    1997 Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumorsOncology Reports.  4:775-778. 1997
    1997 Papillary carcinoma of the thyroid: Can operative management be based solely on fine-needle aspiration?Journal of The American College of Surgeons.  184:605-610. 1997
    1997 Tissue-specific expression of human acahaete-scute homologue-1 in neuroendocrine tumors: Transcriptional regulation by dual inhibitory regionsCell Growth and Differentiation.  8:677-686. 1997
    1997 Conservation of the Drosophila lateral inhibition pathway in human lung cancer: A hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expressionProceedings of the National Academy of Sciences.  94:5355-5360. 1997
    1997 An achaete-scute homologue essential for neuroendocrine differentiation in the lungNature.  386:852-855. 1997
    1997 Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report: Does It Safely Reduce the Blood Transfusion Requirement?Journal of Gastrointestinal Surgery.  1:461-466. 1997
    1997 Implanted programmable insulin pumps: One hundred fifty-three patient years of surgical experienceSurgery.  122:1005-1011. 1997
    1997 Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroidSurgery.  122:1137-1140. 1997
    1996 Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1Surgery.  120:168-173. 1996
    1996 Parathyroidectomy in Maryland: Effects of an endocrine centerSurgery.  120:948-953. 1996
    1995 Follicular lesions of the thyroid: Does frozen section evaluation alter operative management?Annals of Surgery.  222:101-106. 1995
    1995 Adrenocorticotropic hormone-secreting pheochromocytomas: The exception to the ruleSurgery.  118:988-995. 1995
    1992 Derivation of a biologically contained replication system for human immunodeficiency virus type 1Proceedings of the National Academy of Sciences.  89:7678-7682. 1992

    Book

    Year Title Altmetric
    2018 Diagnosis and Management of Hyperparathyroidism.  Ed. 52.  2018
    2016 Illustrative handbook of general surgery: Second edition 2016
    2012 Success in academic surgery: Part 1 2012
    2011 Preface 2011
    2011 The handbook of endocrine surgery 2011
    2010 Preface 2010
    2010 Preface 2010
    2010 Primary hyperparathyroidism.  Ed. 153.  2010

    Chapter

    Year Title Altmetric
    2017 Parathyroid surgery in children.  61-73. 2017
    2015 Thyroid cancer.  539-561. 2015
    2014 Radioguided parathyroidectomy.  151-156. 2014
    2013 Cancer of the Endocrine System.  1112-1142. 2013
    2012 Medullary thyroid cancer.  293-296. 2012
    2012 Thyroid lymphoma and other metastatic lesions.  259-267. 2012
    2012 Fine needle aspiration biopsy of the thyroid: Thyroid lobectomy and subtotal and total thyroidectomy 2012
    2011 Clinical management of primary hyperparathyroidism.  171-178. 2011
    2008 Reoperative Endocrine Surgery.  135-149. 2008
    2007 Thyroid lymphoma and other metastatic lesions.  171-177. 2007
    2005 Hürthle cell adenoma and carcinoma.  123-128. 2005

    Research Overview

  • thyroid and parathyroid surgery, minimally invasive radioguided parathyroidectomy, adrenal surgery, endocrine surgery, neuroendocrine cancer biology
  • Teaching Activities

  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2019) 2019
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Spring Term 2019) 2019
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Spring Term 2019) 2019
  • STP299DI - ENDOCRINE SURGERY (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Spring Term 2018) 2018
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Spring Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Spring Term 2018) 2018
  • 80-509 - DEAN'S ENDOCRINE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Spring Term 2017) 2017
  • STP299AD - SPECIAL TOPIC IN ENDOCRINE SURGERY (Spring Term 2017) 2017
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Fall Term 2016) 2016
  • 80-509 - DEAN'S ACUTE CARE SURGERY ELECTIVE (Spring Term 2016) 2016
  • Education And Training

  • Doctor of Medicine, Duke University 1992
  • Johns hopkins medical institutions, Residency 1999
  • Johns Hopkins Medical Institutions, Postdoctoral Fellowship 2000
  • Full Name

  • Herbert Chen